Delivery Order SPE2DB20D1100-SPE2DB25FE2D5
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 21, 2025, for the supply of Gamunex-C 20 gram/200 milliliter vials with a ceiling value of $28,323.36. This firm fixed-price delivery order is set to be completed by September 12, 2025, and was awarded through the Defense Logistics Agency's Medical Supply Chain without the use of a set-aside designation, indicating it was competitively awarded. The...
- The Defense Logistics Agency awarded a $3,036.70 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Gamunex-C 5 gram/50 milliliter vials. The contract is set to be completed by September 10, 2025, with performance occurring at the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 comprehensive global...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Gamunex-C 10 gram/100 mL vials valued at $18,314.10 with a firm fixed price structure. The contract is non-set-aside and competitively awarded, with an ultimate completion date of September 3, 2025. AmerisourceBergen Drug Corp will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 14, 2025, for the supply of Gamunex-C 40 gram/400 mL vials. The contract, valued at $46,544.00, carries a firm fixed price structure with an ultimate completion date of September 5, 2025. This award represents a non-set-aside competitive procurement and will be performed at the contractor's Conshohocken facility. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Gamunex-C 5 gram/50 ml vials valued at $1,518.35, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a potential value of $999,999,999 and...
- The Defense Logistics Agency awarded a delivery order valued at $9,522.72 to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 milliliter vials. This is a firm fixed price contract with an ultimate completion date of August 18, 2025, and was competitively awarded without a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Gamunex-C 5 gram/50 milliliter vials with a ceiling value of $1,214.68. This is a firm fixed-price delivery order without set-aside designation, with an ultimate completion date of September 15, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $3,540.39 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Gamunex-C 20 gram/200 milliliter vials. The contract is a firm fixed price delivery order with an ultimate completion date of August 14, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement, indicating it was awarded through competitive procedures. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of GAMUNEX-C 20 gram/200 milliliter vials valued at $11,651.54 under a firm fixed-price contract with an ultimate completion date of August 18, 2025. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $40,532.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 milliliter vials, with an ultimate completion date of August 22, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE2D5Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $43,569.46 delivery order on August 21, 2025, for Gamunex-C 20 gram/200 mL vials with a completion date of September 12, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has demonstrated significant capability as a federal medical procurement vendor through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. The company supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This particular delivery order for Gamunex-C, an immunoglobulin product, reflects the company's role in supplying critical pharmaceutical commodities to support Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.6k | 8/21/25 |